Gates Wellcome Leap Commit $100M to Uzima Stillbirth Program
Berlin, Germany, October 12, 2026 The Gates Foundation and Wellcome Leap have announced a combined $100 million commitment to...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
.Gov for New Therapy
Berlin, Germany, October 12, 2026 The Gates Foundation and Wellcome Leap have announced a combined $100 million commitment to...
Carmel, Indiana, U.S., September 29, 2026 Syra Health Corp. has been awarded a three-year public health analytics contract by...
Washington, D.C., U.S., September 28, 2026 The U.S. Food and Drug Administration’s approach to regulating new tobacco products is...
Silver Spring, Maryland, August 18, 2026 The U.S. Food and Drug Administration (FDA) has issued a new discussion paper...
Bethesda, Maryland, August 5, 2026 The National Institutes of Health (NIH), through the National Cancer Institute (NCI) and its...
RICHMOND, Va., July 20, 2026 Virginia’s Advanced Pharmaceutical Manufacturing (APM) Tech Hub has secured a $15.97 million investment from...
WASHINGTON, July 17, 2026 The American Pharmacists Association (APhA) has called on the U.S. Food and Drug Administration (FDA)...
WASHINGTON, D.C., July 14, 2026 A coalition of leading public health organizations, pediatricians, and parents has filed a federal...
SILVER SPRING, Maryland, July 10, 2026 The U.S. Food and Drug Administration (FDA) has proposed a new rule designed...
NEW HAVEN, Conn., July 6, 2026 Invivyd announced that the U.S. Food and Drug Administration (FDA) has issued a...
